New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Declinenews2023-07-17T14:30:32+00:00July 17th, 2023|The New York Times|
Ozempic y su efecto en ‘ruido de la comida’news2023-07-17T12:24:26+00:00July 17th, 2023|The New York Times|
How Women Feel About an Over-the-Counter Birth Control Pillnews2023-07-15T00:34:02+00:00July 15th, 2023|The New York Times|
F.D.A. Approves First U.S. Over-the-Counter Birth Control Pillnews2023-07-13T14:32:37+00:00July 13th, 2023|The New York Times|
Schumer Asks Judicial Policymakers to End Single-Judge Divisions in Texasnews2023-07-11T16:02:38+00:00July 11th, 2023|The New York Times|
Substance Abuse Is Climbing Among Seniorsnews2023-07-09T18:54:52+00:00July 9th, 2023|The New York Times|
Leqembi: lo que hay que saber sobre el fármaco contra el alzhéimernews2023-07-08T11:00:12+00:00July 8th, 2023|The New York Times|
Antibiotic Shortage Could Fuel Rise in Syphilis Ratesnews2023-07-07T14:30:09+00:00July 7th, 2023|The New York Times|
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDAnews2023-07-06T22:20:07+00:00July 6th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
